PMID- 10517113 OWN - NLM STAT- MEDLINE DCOM- 19991119 LR - 20131121 IS - 0040-5930 (Print) IS - 0040-5930 (Linking) VI - 56 IP - 9 DP - 1999 Sep TI - [Recurrent thromboembolisms despite oral anticoagulation in a 76-year-old patient--Trousseau syndrome]. PG - 481-3 AB - We report the case of a 76-year-old man with recurrent thromboses and low-grade chronic disseminated intravascular coagulation despite therapeutic oral anticoagulation with phenprocoumon. Work-up revealed a bronchial carcinoma (NSCCL) with hilar and mediastinal lymph node metastasis. The clinical condition was consistent with Trousseau's syndrome. Based on reports in the literature, the therapy was changed from phenprocoumon to intravenous unfractionated heparin (UFH), which was effective in controlling the thrombotic coagulopathy. For practical reasons, despite lack of established effectiveness in Trousseau's syndrome, therapy was switched to low-molecular-weight heparin (LMWH, nadroparine) in therapeutic dosage of 100 IU/kg body wt. subcutaneously 12 hourly. The patient remained free from further thromboembolic events during the last 6.5 months of his life. This case suggests that LMWH might be a convenient alternative to the established therapy with UFH in Trousseau's syndrome. FAU - Zuger, M AU - Zuger M AD - Zentrallaboratorien Thurgauische Kantonsspitaler, Munsterlingen. FAU - Demarmels Biasiutti, F AU - Demarmels Biasiutti F LA - ger PT - Case Reports PT - English Abstract PT - Journal Article TT - Rezidivierende Thromboembolien trotz oraler Antikoagulation bei einem 76jahrigen Patienten--Trousseau Syndrom. PL - Switzerland TA - Ther Umsch JT - Therapeutische Umschau. Revue therapeutique JID - 0407224 RN - 0 (Anticoagulants) RN - 0 (Heparin, Low-Molecular-Weight) RN - 9005-49-6 (Heparin) RN - Q08SIO485D (Phenprocoumon) SB - IM MH - Aged MH - Anticoagulants/*administration & dosage MH - Carcinoma, Non-Small-Cell Lung/blood/*diagnosis/drug therapy MH - Heparin/administration & dosage MH - Heparin, Low-Molecular-Weight/administration & dosage MH - Humans MH - Injections, Subcutaneous MH - Lung Neoplasms/blood/*diagnosis/drug therapy MH - Male MH - Paraneoplastic Syndromes/blood/*diagnosis/drug therapy MH - Phenprocoumon/*administration & dosage MH - Recurrence MH - Thromboembolism/blood/*diagnosis/drug therapy EDAT- 1999/10/12 00:00 MHDA- 1999/10/12 00:01 CRDT- 1999/10/12 00:00 PHST- 1999/10/12 00:00 [pubmed] PHST- 1999/10/12 00:01 [medline] PHST- 1999/10/12 00:00 [entrez] AID - 10.1024/0040-5930.56.9.481 [doi] PST - ppublish SO - Ther Umsch. 1999 Sep;56(9):481-3. doi: 10.1024/0040-5930.56.9.481.